DigiPath Inc. [stock symbol=”DIGP”] , a provider of reliable testing, education, training, and unbiased news coverage to the cannabis industry, recently announced the addition of Green Life Productions as a new clients for its DigiPath Labs subsidiary. By leveraging its cutting-edge testing equipment and methodologies, the company will provide extensive testing services designed to ensure that the client’s products are safe and efficacious.
Marijuana testing labs like Digipath Inc, Steephill Labs, and Cannalabs are becoming integral in the legal distribution of marijuana. The testing lab industry is currently valued at $850 Million.[stock-engine]
Green Life Productions grows a number of different cannabis strains using a no-till living soil system that reduces ecological impact and enhances patient safety. Under the agreement, DigiPath Labs will test a variety of these strains for moisture content, potency, terpenoids, foreign matter, microbials, mycotoxins, heavy metals, and pesticide residues in order to ensure that they are safe for consumption by patients and produce the desired effects.
Another company doing things right in the marijuana lab testing world is Steep Hill Labs:
Steep Hill Labs, a California-based company, has opened a lab in Albuquerque that will provide quality assurance testing for marijuana plant producers and patients participating in the state’s medical cannabis program.
“Our goal at Green Life Productions is to raise the ethical and ecological standards for medical cannabis growing,” said cofounders Steve Cantwell and Kouanin Villa in a press release announcing the deal. “DigiPath Labs’ commitment to standardization and safety were a perfect fit for our permaculture philosophy. We also love their 48-hour turnaround which allows us to quickly get our products on the shelves of local dispensaries.”
“We have been advocating for a more scientific approach for years, and now we’re finding likeminded growers, such as Steve and Kouanin, who are eager to receive the unbiased information we can offer about their products and use that data to continually refine growing techniques,” says DigiPath CEO Todd Denkin in the same press release announcing the deal. “This is an exciting time to be at the forefront of the medical cannabis industry.”
To learn more, visit the company’s website at www.digipath.com.
Disclaimer: Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: http://www.cannabisfn.com/legal-disclaimer/.